302 East Pettigrew St.
74 articles with Precision BioSciences
Precision Biosciences Announces Collaboration with University of Pennsylvania to Develop Genome Editing Therapeutics
Precision BioSciences today announced an expansion of their ongoing collaboration with the Gene Therapy Program in the Perelman School of Medicine at the University of Pennsylvania.
Precision BioSciences closed on an oversubscribed Series B financing worth $110 million. The funds will be used to continue developing its ARCUS genome editing platform.
Precision BioSciences CSO Derek Jantz will present and join a panel discussion during the DIA (Drug Information Association) 2018 conference.
Precision BioSciences has announced a new name and brand identity for its food and agriculture business.
Precision BioSciences to Present In Vivo Gene Therapy and Ex Vivo Cancer Immunotherapy Data at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
Precision BioSciences, the ARCUS genome editing company with novel product development programs in gene therapy, cancer immunotherapy and non-GMO food, will give three presentations at the upcoming ASGCT 21st Annual Meeting held in Chicago, Illinois, May 16-19, 2018.
ACEA Biosciences, a biotechnology company that develops high performance cell analysis instruments, hosted their 6th annual Cancer Immunotherapy Symposium focused on CAR-T cell and TCR therapy on April 14, 2018 at the W Hotel in Chicago, prior to the 2018 AACR Annual Meeting.
Precision BioSciences Announces Appointment Of Gene Liau, Ph.D. And Bruce Mccreedy, Ph.D. To Management Team
Danziger Innovations And Precision BioSciences Announce Successful Genome Modification Collaboration In Ornamental Plants
Precision BioSciences And Agrivida, Inc. Announce Collaborative Trait Development Agreement And Successful Genetic Modification
Precision BioSciences Announces First Publication of Targeted Knockout Rats Using Engineered Meganuclease Technology
Precision BioSciences Announces Publication of Cotton Trait Stacking Success in Collaboration With Bayer CropScience AG
Precision BioSciences Announces Allowance of Eleventh U.S. Patent Application Related to Genome Editing Nucleases
Precision BioSciences Files Tenth Patent Infringement Lawsuit Against CELLECTIS SA Related to Meganuclease Technology and Requests Permanent Injunction